REACH is a program to energize and empower people living with lupus through movement. The REACH Lupus study is a randomized controlled pilot study to evaluate the REACH program.
Search Tufts Medicine
Tufts Medical Center’s Chief of Pediatric Neurology, Arnold J. Sansevere, MD is here to help us get smart about what is often thought of as an “invisible” injury.
Aortic stenosis (AS) affects over 12.6 million adults and causes an estimated 102,700 deaths annually. There is interest in novel approaches to identify valve disease earlier the disease course before symptoms occur. We previously used machine learning (ML) to develop a system for fully automated AS screening. Here we are validating the performance of this new method for identifying AS.
This is a prospective, multi-center, multi-arm, double-blind, randomized, controlled platform trial evaluating antiviral and other therapeutics for use in the treatment of Post-Acute Sequelae of COVID-19 (PASC). The hypothesis is that persistent viral infection and/or overactive/chronic immune response are underlying contributors to PASC and that antiviral and other applicable therapies may result in viral clearance or decreased inflammation and improvement in PASC symptoms.